Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva van Rooij

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Cardiovascular Research|February 17, 2025
Cardiomyocyte SORBS2 expression increases in heart failure and regulates integrin interactions and extracellular matrix compositionLouk T Timmer, Elvira den Hertog, Danielle Versteeg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2018
Profiling proliferative cells and their progeny in damaged murine heartsKai Kretzschmar, Yorick Post, Marie Bannier-Hélaouët, et al.
Iscience|March 4, 2025
EPAS1 induction drives myocardial degeneration in desmoplakin-cardiomyopathyEirini Kyriakopoulou, Sebastiaan J van Kampen, Martijn Wehrens, et al.
Nature Cardiovascular Research|January 2, 2025
Cross-species comparison reveals that Hmga1 reduces H3K27me3 levels to promote cardiomyocyte proliferation and cardiac regenerationMara Bouwman, Dennis E M de Bakker, Hessel Honkoop, et al.
European Journal of Heart Failure|March 11, 2025
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the HeartAlessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
European Journal of Heart Failure|November 22, 2024
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesSophie Van Linthout, Konstantinos Stellos, Mauro Giacca, et al.
Stem Cell Reports|March 3, 2023
PITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathySebastiaan J van Kampen, Su Ji Han, Willem B van Ham, et al.
Scientific Reports|June 20, 2020
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
Scientific Reports|October 3, 2020
Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
European Journal of Heart Failure|January 24, 2014
Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure ResearchMathias Hohl, Hossein Ardehali, Francisco J Azuaje, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Cardiovascular Research|February 17, 2025
Cardiomyocyte SORBS2 expression increases in heart failure and regulates integrin interactions and extracellular matrix compositionLouk T Timmer, Elvira den Hertog, Danielle Versteeg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2018
Profiling proliferative cells and their progeny in damaged murine heartsKai Kretzschmar, Yorick Post, Marie Bannier-Hélaouët, et al.
Iscience|March 4, 2025
EPAS1 induction drives myocardial degeneration in desmoplakin-cardiomyopathyEirini Kyriakopoulou, Sebastiaan J van Kampen, Martijn Wehrens, et al.
Nature Cardiovascular Research|January 2, 2025
Cross-species comparison reveals that Hmga1 reduces H3K27me3 levels to promote cardiomyocyte proliferation and cardiac regenerationMara Bouwman, Dennis E M de Bakker, Hessel Honkoop, et al.
European Journal of Heart Failure|March 11, 2025
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the HeartAlessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
European Journal of Heart Failure|November 22, 2024
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesSophie Van Linthout, Konstantinos Stellos, Mauro Giacca, et al.
Stem Cell Reports|March 3, 2023
PITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathySebastiaan J van Kampen, Su Ji Han, Willem B van Ham, et al.
Scientific Reports|June 20, 2020
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
Scientific Reports|October 3, 2020
Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapyTim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
European Journal of Heart Failure|January 24, 2014
Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure ResearchMathias Hohl, Hossein Ardehali, Francisco J Azuaje, et al.
Pageof 12